Westchester Capital Management (New York)’s Biote Corp. Warrant BTMDW Stock Holding History

Westchester Capital Management (New York)’s Portfolio BTMDW Stock Details BTMDW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-99,997	Closed	-$42K	–	379
2023 Q1	$42K	Hold	99,997	–	–	﹤0.01%	307
2022 Q4	$25K	Hold	99,997	–	–	﹤0.01%	389
2022 Q3	$35K	Hold	99,997	–	–	﹤0.01%	421
2022 Q2	$43K	Buy	+99,997	New	+$53.9K	﹤0.01%	380

Other funds holding BTMDW

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Westchester Capital Management (New York)'s BTMDW Position: Q2 2023 in Review

Westchester Capital Management (New York) sold out of Biote Corp. Warrant (BTMDW) in Q2 2023, closing a stake of 99,997 shares — an estimated $42K sold.

Westchester Capital Management (New York) first reported a position in BTMDW in Q2 2022 and held it in 4 quarters. The position peaked at $43K in Q2 2022. 2 funds tracked by Wall St. Rank hold BTMDW as of Q2 2023.

Westchester Capital Management (New York) reported no remaining Biote Corp. Warrant position as of Q2 2023 after selling out during the quarter.
Westchester Capital Management (New York) sold 99,997 Biote Corp. Warrant shares in Q2 2023, an estimated $42K.
Westchester Capital Management (New York) first reported a position in Biote Corp. Warrant in Q2 2022 and held it in 4 quarters.
Westchester Capital Management (New York)'s Biote Corp. Warrant position peaked at $43K in Q2 2022.
2 funds tracked by Wall St. Rank held Biote Corp. Warrant as of Q2 2023.

Based on Westchester Capital Management (New York)'s 13F filing for Q2 2023, filed 14 Aug 2023.